An intragastric device includes an elongated member having a proximal end and a distal end and an anchor connected to the elongated member. The anchor includes a stem, a first arch and a second arch, and a curvilinear element. The stem includes a proximal end and a distal end. The distal end of the stem is attached to the proximal end of the elongated member. Each arch has first and second ends and a proximal peak therebetween. The first end of each arch is attached to the proximal end of the stem, and the second end of each arch extends radially away from the stem. The curvilinear element connects the second end of the first arch to the second end of the second arch.

An intragastric weight-loss device is disclosed. The device includes a proximal occlusion member comprising a spiral structure, a bridging member, and a distal occlusion member. The spiral structure can be configured to spiral into a bulbous shape when the proximal occlusion member is delivered into the stomach. The bridging member can extend from the proximal occlusion member. The distal occlusion member can be coupled to a distal end of the bridging member. The proximal occlusion member can be configured to intermittently obstruct a pyloric valve of a patient such that passage of food through the pyloric valve is slowed.

An intestinal device, or a non-constrictive cuff, is configured for placement around an intestine. In the closed position the non-constrictive cuff is configured to be around at least part or all of an intestine, wherein the non-constrictive cuff does not constrict the portion of the intestine when deployed. A first intestinal device can be deployed for placement around a portion of an intestine, wherein a proximal end of the first intestinal device is configured to longitudinally overlap a distal end of a second intestinal device when disposed around an intestine. A method of use for a first intestinal device or non-constrictive cuff is also disclosed.

The present disclosure is related to medical devices, stents, occlusion devices, and the like, to occlude, limit, or otherwise facilitate a regulated fluid flow between body lumens. A medical device may be a pyloric occlusion device with first and second configurations. In the second configuration, the elongate body may comprise a first retention member, a second retention member, and a cylindrical saddle region configured to span a pyloric sphincter. The first retention member and the second retention member each include an inner wall, an outwardly circumferential wall, and an outer wall, a first interface connecting the inner wall and the outwardly circumferential wall, and a second interface connecting the outwardly circumferential wall and the outer wall. At least one of the outwardly circumferential wall or the interface of either the first retention member or the second retention member is configured to appose a pyloric antrum wall.

A method for performing a medical procedure in an intestine of a patient is provided. The method comprises providing a system comprising: a catheter for insertion into the intestine, the catheter comprising: an elongate shaft comprising a distal portion; and a functional assembly positioned on the shaft distal portion and comprising at least one treatment element. The catheter is introduced into the patient, and target tissue is treated with the at least one treatment element. The target tissue comprises mucosal tissue of the small intestine, and the medical procedure can be configured to treat polycystic ovarian syndrome (PCOS).

An apparatus comprises a sleeve, a seal, and an anchor assembly. The sleeve is flexible and non-permeable and is configured to fit in a duodenum. The seal is positioned at the proximal end of the sleeve and is configured to seal the proximal end of the sleeve against the stomach mucosa, the pylorus, or the duodenum mucosa. The anchor assembly comprises a pair of atraumatic anchor ends and a resilient member positioned between the anchor ends. At least a portion of the resilient member extends along at least a portion of the length of the sleeve. The resilient member is configured to bias the anchor ends generally toward each other, to thereby substantially anchor the sleeve in the duodenum. The sleeve is configured to prevent chyme from contacting the mucosa of the duodenum; and to prevent enzymes excreted in the duodenum from mixing with chyme in the duodenum.

Systems and methods for anchoring and restraining gastrointestinal prostheses are disclosed. In various examples, the systems and methods include securing a gastrointestinal device within a patient's anatomy by extending an anti-migration anchor through a plurality of portions of the gastrointestinal device to couple together the plurality of portions of the gastrointestinal device. In some examples, the anti-migration anchor extends through tissue situated between the plurality of portions of the gastrointestinal device.

The present disclosure relates generally to stents, systems, and methods for anchoring devices within a body lumen by cooperation between the device and the body musculature. A device comprising an elongate tubular member may be deployed within a body lumen, where the body lumen includes a sphincter that regulates flow through the body lumen. The elongate tubular member includes a sleeve formed from a flexible membrane and one or more stents disposed at either or both ends of the sleeve. In some embodiments, the stents may be treatment stents configured to treat a portion of the body lumen. The elongate tubular member may be deployed within the body lumen such that the flexible membrane aligns with and moves in coordination with the sphincter, thereby increasing retention forces acting upon the elongate tubular member when the sphincter is closed to minimize treatment stent migration.

A sphincter assist device includes a plurality of interconnected and adjacent links which define a ring. Each link includes a body section and a latch cam. The body section includes a first set of side beams and a first set of snap arms. The latch cam includes a post extending from the body section and a cam disposed at an end portion of the post. The cam is engagable with the first set of snap arms of an adjacent link. Translation of the cam displaces the first set of snap arms and the first set of side beams to transition the sphincter assist device between open and closed configurations. The first set of snap arms, in combination with the first set of side beams, exert a positive non-linear force profile on the cam, thus defining a non-linear force profile of the sphincter assist device between the open and closed configurations.

An implantable device having an expandable element, such as a balloon, exerting a radially-outwardly directed anti-migration force to hold the implantable device in place. The implantable device occlusion device may be an occlusion device configured to be inserted through a body passage. The implantable device may include a first component and a second component expandable within a lumen of the first component to exert an antimigration force against the first component. The first component may be an expandable stent coated to resist tissue ingrowth, and the second component may be an expandable balloon configured to exert an anti-migration force against the expandable stent.